Nuo Therapeutics, Inc. engages in the development and sale of biomedical products for chronic wound care. It offers Aurix point of care technology for the separation of autologous blood to produce a platelet-based therapy for the chronic wound care market. The company was founded on April 29, 1998 and is headquartered in Houston, TX.